BusinessNovelion Therapeutics Observes Familial Hypercholesterolemia Awareness DayBy Nasdaq OMXSep 24, 2017, 12:00 PM UTC
BusinessNovelion Therapeutics’ Subsidiary Launches JUXTAPID® (lomitapide) in JapanBy Nasdaq OMXDec 16, 2016, 1:36 PM UTC
BusinessCymaBay Therapeutics Announces Positive Results from its Pilot Phase 2 Clinical Study of MBX-8025 in Patients with Homozygous Familial HypercholesterolemiaBy Nasdaq OMXMar 17, 2016, 8:01 PM UTC
